Overlapping clinical presentation of Mycoplasma-induced rash and mucositis and drug-induced Stevens Johnson Syndrome: A case report

被引:0
作者
Marquart, Elias [1 ]
Kinaciyan, Tamar [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[2] Med Univ Vienna, Dept Dermatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
来源
IDCASES | 2023年 / 33卷
关键词
Mycoplasma pneumoniae; Cutaneous adverse drug reaction (CADR); Beta-lactam antibiotics; NSAID; Extensive allergy passport; Allergological work -up; TOXIC EPIDERMAL NECROLYSIS;
D O I
10.1016/j.idcr.2023.e01888
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Mycoplasma pneumoniae is a worldwide occurring common bacterial agent for communityacquired pneumonia especially in children and young people with high contagiousness. Extrapulmonary complications such as cardiopulmonary, gastrointestinal, neurological and mucocutaneous manifestations including Mycoplasma pneumoniae-induced rash and mucositis (MIRM) may occur especially in adults. MIRM is an important differential diagnosis of Stevens Johnson Syndrome (SJS). Both clinically present similar as mucocutaneous erosive eruptions but have different etiologies.Case presentation: We present an atypical case of a 36-year-old female with overlapping clinical features of MIRM and SJS. The patient presented to our allergy-outpatient clinic after recovering from mucocutaneous erosive eruptions and receiving an allergy-passport upon discharge for all drugs administered during the course of treatment including a subsequent ban of all beta-lactam antibiotics and NSAIDs for the future resulting in a desperate patient and treating physicians. A positive result of Mycoplasma pneumoniae in the sputum culture upon discharge was unnoticed. An allergological work-up with skin testing and drug provocation testing with the culprit drugs and safe alternatives was performed which resulted negative. Therefore, a new allergy passport was issued with drug alternatives that the patient may use in the future. A diagnosis of MIRM was subsequently made.Discussion: The present case report depicts the diagnostic algorithm in an atypical case with overlapping clinical features of a MIRM and SJS.Conclusion: Patients with atypical mucocutaneous eruptions of possible allergological etiology should receive a careful allergological work-up in an experienced tertiary referral center to reduce the number of inadequate allergy passport distribution.
引用
收藏
页数:3
相关论文
共 10 条
  • [1] Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests
    Assier, Haudrey
    Valeyrie-Allanore, Laurence
    Gener, Gwendeline
    Carvalh, Muriel Verlinde
    Chosidow, Olivier
    Wolkenstein, Pierre
    [J]. CONTACT DERMATITIS, 2017, 77 (05) : 297 - 302
  • [2] A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions
    Barbaud, A.
    Collet, E.
    Milpied, B.
    Assier, H.
    Staumont, D.
    Avenel-Audran, M.
    Grange, A.
    Amarger, S.
    Girardin, P.
    Guinnepain, M. -T.
    Truchetet, F.
    Lasek, A.
    Waton, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (03) : 555 - 562
  • [3] Brockow K, 2002, ALLERGY, V57, P45
  • [4] Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic review
    Canavan, Theresa N.
    Mathes, Erin F.
    Frieden, Ilona
    Shinkai, Kanade
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (02) : 239 - U265
  • [5] UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016
    Creamer, D.
    Walsh, S. A.
    Dziewulski, P.
    Exton, L. S.
    Lee, H. Y.
    Dart, J. K. G.
    Setterfield, J.
    Bunker, C. B.
    Ardern-Jones, M. R.
    Watson, K. M. T.
    Wong, G. A. E.
    Philippidou, M.
    Vercueil, A.
    Martin, R. V.
    Williams, G.
    Shah, M.
    Brown, D.
    Williams, P.
    Mustapa, M. F. Mohd
    Smith, C. H.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (06) : 1194 - 1227
  • [6] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update
    Dodiuk-Gad, Roni P.
    Chung, Wen-Hung
    Valeyrie-Allanore, Laurence
    Shear, Neil H.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2015, 16 (06) : 475 - 493
  • [7] Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development
    Jiang, Zhulin
    Li, Shuihong
    Zhu, Cuiming
    Zhou, Runjie
    Leung, Polly H. M.
    [J]. PATHOGENS, 2021, 10 (02): : 1 - 18
  • [8] Classification of Extrapulmonary Manifestations Due to Mycoplasma pneumoniae Infection on the Basis of Possible Pathogenesis
    Narita, Mitsuo
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [9] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures
    Schneider, Jeremy A.
    Cohen, Philip R.
    [J]. ADVANCES IN THERAPY, 2017, 34 (06) : 1235 - 1244
  • [10] Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis
    Wolkenstein, P
    Chosidow, O
    Flechet, ML
    Robbiola, O
    Paul, M
    Dume, L
    Revuz, J
    Roujeau, JC
    [J]. CONTACT DERMATITIS, 1996, 35 (04) : 234 - 236